Does AMBRISENTAN Cause Stent placement? 100 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Stent placement have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.1% of all adverse event reports for AMBRISENTAN.
100
Reports of Stent placement with AMBRISENTAN
0.1%
of all AMBRISENTAN reports
6
Deaths
75
Hospitalizations
How Dangerous Is Stent placement From AMBRISENTAN?
Of the 100 reports, 6 (6.0%) resulted in death, 75 (75.0%) required hospitalization, and 2 (2.0%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 100 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which AMBRISENTAN Alternatives Have Lower Stent placement Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE